Annual Revenue
$145.80 K
+$26.00 K+21.70%
December 1, 2023
Summary
- As of February 7, 2025, BRTX annual revenue is $145.80 thousand, with the most recent change of +$26.00 thousand (+21.70%) on December 1, 2023.
- During the last 3 years, BRTX annual revenue has risen by +$68.80 thousand (+89.35%).
- BRTX annual revenue is now -76.82% below its all-time high of $628.90 thousand, reached on December 31, 2015.
Performance
BRTX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$233.60 K
+$144.50 K+162.18%
September 1, 2024
Summary
- As of February 7, 2025, BRTX quarterly revenue is $233.60 thousand, with the most recent change of +$144.50 thousand (+162.18%) on September 1, 2024.
- Over the past year, BRTX quarterly revenue has increased by +$202.90 thousand (+660.91%).
- BRTX quarterly revenue is now at all-time high.
Performance
BRTX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$377.00 K
+$202.90 K+116.54%
September 1, 2024
Summary
- As of February 7, 2025, BRTX TTM revenue is $377.00 thousand, with the most recent change of +$202.90 thousand (+116.54%) on September 1, 2024.
- Over the past year, BRTX TTM revenue has increased by +$246.80 thousand (+189.55%).
- BRTX TTM revenue is now -40.05% below its all-time high of $628.90 thousand, reached on December 31, 2015.
Performance
BRTX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
BRTX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +21.7% | +660.9% | +189.6% |
| 3 y3 years | +89.3% | +4572.0% | +719.6% |
| 5 y5 years | +31.4% | +4572.0% | +719.6% |
BRTX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +217.0% | at high | +6213.5% | at high | +756.8% |
| 5 y | 5-year | at high | +217.0% | at high | +6213.5% | at high | +756.8% |
| alltime | all time | -76.8% | +8476.5% | at high | >+9999.0% | -40.0% | >+9999.0% |
BioRestorative Therapies Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $233.60 K(+162.2%) | $377.00 K(+116.5%) |
| Jun 2024 | - | $89.10 K(+154.6%) | $174.10 K(+16.5%) |
| Mar 2024 | - | $35.00 K(+81.3%) | $149.50 K(+2.5%) |
| Dec 2023 | $145.80 K(+21.7%) | $19.30 K(-37.1%) | $145.80 K(+12.0%) |
| Sep 2023 | - | $30.70 K(-52.4%) | $130.20 K(+1.3%) |
| Jun 2023 | - | $64.50 K(+106.1%) | $128.50 K(-4.9%) |
| Mar 2023 | - | $31.30 K(+745.9%) | $135.10 K(+12.8%) |
| Dec 2022 | $119.80 K(+160.4%) | $3700.00(-87.2%) | $119.80 K(-1.1%) |
| Sep 2022 | - | $29.00 K(-59.2%) | $121.10 K(+21.0%) |
| Jun 2022 | - | $71.10 K(+344.4%) | $100.10 K(+127.5%) |
| Mar 2022 | - | $16.00 K(+220.0%) | $44.00 K(-4.3%) |
| Dec 2021 | $46.00 K(-40.3%) | $5000.00(-37.5%) | $46.00 K(-20.7%) |
| Sep 2021 | - | $8000.00(-46.7%) | $58.00 K(-10.8%) |
| Jun 2021 | - | $15.00 K(-16.7%) | $65.00 K(-5.8%) |
| Mar 2021 | - | $18.00 K(+5.9%) | $69.00 K(-10.4%) |
| Dec 2020 | $77.00 K(-40.8%) | $17.00 K(+13.3%) | $77.00 K(-16.3%) |
| Sep 2020 | - | $15.00 K(-21.1%) | $92.00 K(-20.0%) |
| Jun 2020 | - | $19.00 K(-26.9%) | $115.00 K(-9.4%) |
| Mar 2020 | - | $26.00 K(-18.8%) | $127.00 K(-2.3%) |
| Dec 2019 | $130.00 K(+17.1%) | $32.00 K(-15.8%) | $130.00 K(+2.4%) |
| Sep 2019 | - | $38.00 K(+22.6%) | $127.00 K(+10.4%) |
| Jun 2019 | - | $31.00 K(+6.9%) | $115.00 K(-5.0%) |
| Mar 2019 | - | $29.00 K(0.0%) | $121.00 K(+9.0%) |
| Dec 2018 | $111.00 K | $29.00 K(+11.5%) | $111.00 K(-7.5%) |
| Sep 2018 | - | $26.00 K(-29.7%) | $120.00 K(+9.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | $37.00 K(+94.7%) | $110.00 K(+18.3%) |
| Mar 2018 | - | $19.00 K(-50.0%) | $93.00 K(+14.8%) |
| Dec 2017 | $81.00 K(+122.5%) | $38.00 K(+137.5%) | $81.00 K(+65.0%) |
| Sep 2017 | - | $16.00 K(-20.0%) | $49.10 K(+28.9%) |
| Jun 2017 | - | $20.00 K(+185.7%) | $38.10 K(+11.1%) |
| Mar 2017 | - | $7000.00(+14.8%) | $34.30 K(-5.8%) |
| Dec 2016 | $36.40 K(-94.2%) | $6100.00(+22.0%) | $36.40 K(-84.1%) |
| Sep 2016 | - | $5000.00(-69.1%) | $229.40 K(-28.4%) |
| Jun 2016 | - | $16.20 K(+78.0%) | $320.50 K(-29.3%) |
| Mar 2016 | - | $9100.00(-95.4%) | $453.10 K(-28.0%) |
| Dec 2015 | $628.90 K(+51.2%) | $199.10 K(+107.2%) | $628.90 K(+23.4%) |
| Sep 2015 | - | $96.10 K(-35.4%) | $509.60 K(-11.1%) |
| Jun 2015 | - | $148.80 K(-19.5%) | $573.40 K(-4.5%) |
| Mar 2015 | - | $184.90 K(+131.7%) | $600.50 K(+44.4%) |
| Dec 2014 | $416.00 K(>+9900.0%) | $79.80 K(-50.1%) | $416.00 K(+23.7%) |
| Sep 2014 | - | $159.90 K(-9.1%) | $336.20 K(+90.6%) |
| Jun 2014 | - | $175.90 K(>+9900.0%) | $176.40 K(>+9900.0%) |
| Mar 2014 | - | $400.00(+300.0%) | $900.00(-55.0%) |
| Dec 2013 | $1700.00(-89.1%) | - | - |
| Sep 2013 | - | $100.00(-75.0%) | $2000.00(-71.8%) |
| Jun 2013 | - | $400.00(-63.6%) | $7100.00(-57.5%) |
| Mar 2013 | - | $1100.00(+175.0%) | $16.70 K(+7.1%) |
| Dec 2012 | $15.60 K | $400.00(-92.3%) | $15.60 K(+2.6%) |
| Sep 2012 | - | $5200.00(-48.0%) | $15.20 K(+52.0%) |
| Jun 2012 | - | $10.00 K | $10.00 K |
FAQ
- What is BioRestorative Therapies annual revenue?
- What is the all time high annual revenue for BioRestorative Therapies?
- What is BioRestorative Therapies annual revenue year-on-year change?
- What is BioRestorative Therapies quarterly revenue?
- What is the all time high quarterly revenue for BioRestorative Therapies?
- What is BioRestorative Therapies quarterly revenue year-on-year change?
- What is BioRestorative Therapies TTM revenue?
- What is the all time high TTM revenue for BioRestorative Therapies?
- What is BioRestorative Therapies TTM revenue year-on-year change?
What is BioRestorative Therapies annual revenue?
The current annual revenue of BRTX is $145.80 K
What is the all time high annual revenue for BioRestorative Therapies?
BioRestorative Therapies all-time high annual revenue is $628.90 K
What is BioRestorative Therapies annual revenue year-on-year change?
Over the past year, BRTX annual revenue has changed by +$26.00 K (+21.70%)
What is BioRestorative Therapies quarterly revenue?
The current quarterly revenue of BRTX is $233.60 K
What is the all time high quarterly revenue for BioRestorative Therapies?
BioRestorative Therapies all-time high quarterly revenue is $233.60 K
What is BioRestorative Therapies quarterly revenue year-on-year change?
Over the past year, BRTX quarterly revenue has changed by +$202.90 K (+660.91%)
What is BioRestorative Therapies TTM revenue?
The current TTM revenue of BRTX is $377.00 K
What is the all time high TTM revenue for BioRestorative Therapies?
BioRestorative Therapies all-time high TTM revenue is $628.90 K
What is BioRestorative Therapies TTM revenue year-on-year change?
Over the past year, BRTX TTM revenue has changed by +$246.80 K (+189.55%)